Özet:

The prognostic importance of the SYNTAX II score (SS-II) is well known in patients with chronic coronary syndrome. However, primary percutaneous coronary initiative (PKG) applied ST-segment preserves uncertainty in the ability to predict mortality in patients with increased myocardial infarction (STYMI). Therefore, we aimed at investigating the prognostic accuracy of SS-II in STYMI patients with primary PKG. Methods: 743 STYME patients treated with Primary PKG were retroactively analyzed. The work population was divided into three groups according to SS-II and was defined as SS-IIDUCH ≤ 22.5 (n = 245), 22.5 < SS-IIORTA ≤ 31 (n = 243) and SS-IIHYCH > 31 (n = 255). Hospital and long-term mortality were defined as clinical conclusions of the study. Results: Hospital mortality (%15 -%0.4 -%0.8, p<0,001) and all causes-related deaths during follow-up (%32.2 -%6.6 - 2,%9, p<0,001) were significantly higher in the SS-IIHIGH group, compared to the other two groups. Also, the Kaplan-Meier analysis showed that the SS-II > 31 group had a significantly higher mortality incidence (p [log-rank] < 0.001). SS-II > 31 was defined as an independent predictor of all causes-related mortality (Hazard ratio 5.22% 95% confidence range 2.11-12.87 p<0,001). For all causes-related deaths, SS-II, anatomical and logistical clinical SS, modified age-creatine-injection fraction score (ACEF) and the remaining field values under the curve obtained from the ROC analysis of GRACE scores were 0.82, 0.71, 0.81, 0.82 and 0.82 respectively. (p < 0,001) Result: SS-II has an increased predictive ability for hospitalized and long-term mortality in p-PKG-applicated STYME patients. (SETB-2021-11-322)

Anahtar Kelimeler: